NCT02777723 - Study to Evaluate the Efficacy and Safety of CKD-350 | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions

Dry Eye Syndrome

Interventions

DRUG

Xenobella

Hypotonic 0.3% Sodium Hyaluronate

DRUG

Isotonic 0.3% Sodium Hyaluronate

Trial Locations (14)

NOT_YET_RECRUITING

Chungnam National University Hospital, Daejeon

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

RECRUITING

Kyungpook National University Hospital, Daegu

RECRUITING

Pusan National University Hospital, Pusan

RECRUITING

Chonbuk National University Hospital, Jeonju

RECRUITING

Chonnam National University Hospital, Gwangju

RECRUITING

Asan Medical Center, Seoul

NOT_YET_RECRUITING

Gangnam Severance Hospital, Seoul

RECRUITING

Korea University ANAM Hospital, Seoul

RECRUITING

Korea University GURO Hospital, Seoul

RECRUITING

Samsung Medical Center, Seoul

NOT_YET_RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

The Catholic University of Korea Seoul ST. MARY'S Hospital, Seoul

RECRUITING

Yonsei University Severance Hospital, Seoul